用左旋多巴-示差脉冲伏安法间接测定生物样品中的铝

人体内摄入过多的铝可能导致或促进阿尔茨海默氏病 ( Alzheimer s disease)、帕金森氏病( Parkinson s disease)及透析脑病 ( Dialysis encephalopathy)的发病 [1] .原子吸收光谱法、能量分布 X射线光谱法、 X射线微探针分析法、激光微探针质量分析法和核显微法曾用于测定脑铝 .这些方法在样品制作过程中易被污染 [2 ,3] ,仪器昂贵 ,灵敏度不高 ,而且均不能用于人体液和脑铝的在体检测 .由于铝的还原电位约 - 1 .7V,易受 H+干扰 ,直接测定铝有困难 .吸附伏安法利用铝与染料的配合物的电化学响应来测定环境和生物制品中的铝 ,检测下限达 1…     

Trace aluminum determination and sampling problems of archeological bone employing destructive neutron activation analysis

A destructive neutron activation analysis procedure was developed for determining trace aluminum content in bone. It was found that soil contamination can influence the aluninum bone levels in prehistoric bone specimens. These maximum aluninum content values for prehistoric bone are larger than those of modern bone and comparable to aluminum levels present in bone from renal patients.     

Interactions of hydrosiloxane and vinylsiloxane groups with aluminum oxide surfaces

Silicone-based materials often contain vinylsiloxane and hydrosiloxane groups for cross-linking by a radical or addition reaction. Such functional groups can influence the interactions with fillers or with surfaces of substrates when used as adhesives. This work examined how these functional groups interact with aluminum oxide surfaces. For this purpose, aluminum oxide powders with large surface areas of 150 m²/g and different acid-base properties were examined. Siloxanes were applied as thin layers to mainly obtain information from the interphase by vibrational spectroscopy. It was observed that vinyl groups show low interactions with aluminum oxide surfaces even at elevated temperatures. In contrast to this, hydrosiloxanes undergo strong interactions and reactions with aluminum oxides already at room temperature. Activated Si─H species were observed as an intermediate state. On the one hand, interactions and reactions might contribute to adhesion, but on the other hand, the cross-linking reaction can be influenced near the surface, leading to lower mechanical strength.     

Effects of photodynamic therapy on the absorption properties of disulphonated aluminum phthalocyanine in tumor-bearing mice

Time-resolved reflectance spectroscopy was performed on tumor-bearing mice, administered with disulphonated aluminum phthalocyanine (AlS(2)Pc, 5 mg/kg body weight), before, during and after photodynamic therapy. This allowed us to evaluate the absorption spectrum of AlS(2)Pc in vivo from 610 to 700 nm, and to investigate how the therapeutic irradiation affects it. Two tumor locations (intraderma on the back and intramuscular in the leg), and two uptake times (3 and 12 h) were considered. As already observed previously, the absorption spectrum of AlS(2)Pc in vivo is centered at 680-685 nm. The irradiation causes a blue-shift of the measured line shape, more or less marked depending on the experimental conditions. A reduction in absorption is also often observed upon illumination with therapeutic light doses.     

PHOTOBLEACHING OF PORPHYRINS USED IN PHOTODYNAMIC THERAPY AND IMPLICATIONS FOR THERAPY

Abstract— The development of an extraction procedure to quantitate dihematoporphyrin ether (DHE) concentration in tissues correlated to fluorescence measurements from instrumentation developed for in vivo fluorimetry was examined. In vivo fluorometric results from mouse mammary carcinoma (SMT-F) were calibrated against results of the chemical extraction assay quantitated spectrophotometrically. Fluorescence and drug extractable levels increase in a linear fashion with injected dose. Loss of porphyrin fluorescence (photobleaching) and intra-tumoral porphyrin level has been demonstrated both in vitro (NHIK cells) and in vivo (SMT-F tumor) during illumination with light following exposure to Hpd or DHE. This process is essentially independent of porphyrin tumor level in vivo and could lead to tumor protection at very low porphyrin levels. On the other hand, this photobleaching process which occurs concurrent with cellular inactivation and tissue damage due to the photodynamic process can be exploited to protect normal tissue during photodynamic therapy (PDT) and thus greatly enhance the therapeutic ratio. This has been demonstrated in patients undergoing PDT.     

Photodynamic activity of dibiotinylated aluminum sulfophthalocyanine in vitro and in vivo

The photodynamic activity of dibiotinylated aluminum sulfophthalocyanine was studied in vitro and in vivo. Dibiotinylated aluminum sulfophthalocyanine provided enhanced phototoxic action on OAT-75 cell monolayers as compared with the parent drug. Photodynamic therapy of mice with Ehrlich carcinoma using dibiotinylated aluminum sulfophthalocyanine (0.25 mg/kg) resulted in enhanced inhibition of tumor growth, pronounced vascular damage (thrombosis and destruction of vascular walls) and eventual tumor necrosis.     

Serum aluminum determination by instrumental neutron activation analysis in long-term haemodialysis patients

Serum aluminum levels were determined by instrumental neutron activation analysis in 31 patients undergoing long-term haemodialysis. Aluminum-28 1.778 MeV (T _1/2=2.24 min) γ-rays produced by the thermal neutron reaction²⁷Al(n,γ)²⁸Al were detected. Successive irradiation of the samples at epithermal neutron fluence was performed to correct for the interference from the fast neutron reaction³¹P(n,α)²⁸Al. Serum aluminum level in this group of subjects was adequately represented by a lognormal distribution with a mean and variance of 16.5 μg/l and 16.8 μg/l, respectively. The results obtained were found to be in agreement with serum aluminum determination performed by electrothermal atomic absorption spectrophotometry (r ²=0.97). Instrumental neutron activation can provide a rapid technique to routinely monitor long-term haemodialysis patients in order to identify individuals at greater risk to develop aluminum toxicity.     

Nano-LC-MS/MS for the monitoring of angiotensin IV in rat brain microdialysates: limitations and possibilities

To broaden our knowledge about the central role of the angiotensin IV (Ang IV) peptide, we aimed to monitor its extracellular concentration in the brain using in vivo microdialysis. Ang IV was measured in the dialysates using a previously developed nano-LC-MS/MS assay with an LOD of 50 pM. Using this assay, baseline levels of Ang IV in dialysates from different brain structures were undetectable. However, immediately after microdialysis probe insertion, Ang IV could be detected in a concentration that varied between 120 and 187 pM. Using the zero-net-flux method, the extracellular levels of Ang IV in the striatum were estimated at 46 pM. These data may indicate that Ang IV is mainly present intracellularly. In addition, Ang IV was clearly measurable after striatal perfusion of Ang II. On the other hand, our nano-LC-MS/MS method was successful for the detection of Met-enkephalin and neurotensin in dialysates from the rat. In conclusion, the nano-LC-MS/MS method coupled with microdialysis is well suited to monitor the biologically significant conversion between Ang II and Ang IV in vivo, but physiological extracellular levels of Ang IV appear too low to be detected.     

Determination of aluminum levels in serum and red blood cells from long-term haemodialysis patients using instrumental neutron activation analysis

Aluminum levels of serum and red blood cell (RBC) were determined by instrumental neutron activation analysis (INAA) in 15 patients undergoing long-term haemodialysis. In the sample, aluminum was bombarded with thermal neutrons due to ²⁷Al(n,γ)²⁸Al and was determined by measuring 1779 keV gamma-ray of ²⁸Al (T _1/2 = 2.24 min) with a HPGe detector. Phosphorus, causing an important interference by the fast neutron reaction, ³¹P(n,α)²⁸Al, was determined by the photometric method to correct the net-area under the ²⁸Al gamma-peak. The one-sample Kolmogorov-Smirnov test was used to control the normality distribution of the aluminum levels in serum and RBC. The results obtained were found to be in agreement with the serum aluminum determination performed by electrothermal atomic absorption spectrophotometry. The statistical results show a correlation between the aluminum levels of serum and RBC. This revised version was published online in July 2006 with corrections to the Cover Date.     

Cathodic electrochemiluminescence at double barrier Al/Al2O3/Al/Al2O3 tunnel emission electrodes

Double insulating barrier tunnel emission electrodes were fabricated by adding a new pure aluminum layer upon oxidized aluminum electrodes by vacuum evaporation and thermally oxidizing the new aluminum layer in air at room temperature. Resulting Al/Al₂O₃/Al/Al₂O₃ electrodes allow the use of various aluminum alloys in the electrode body necessary for hardness or shaping ability of the electrode while obtaining the luminescence properties of pure aluminum oxide. During electrical excitation of luminescent labels by cathodic hot electron injection into aqueous electrolyte solution, the background noise is mainly based on high-field-induced solid-state electroluminescence and F-center luminescence of the outer aluminum oxide film. The more defect states and/or impurity centers the outer oxide film contains, the higher is the background emission intensity. The present electrode fabrication method provides a considerable improvement in signal-to-noise ratio for time-resolved electrochemiluminescence (TR-ECL) measurements when the original native oxide film of the electrode body contains luminescence centers displaying long-lived luminescence. The excellent performance of the present electrodes is demonstrated by extremely low-level detection of Tb(III) chelates, luminol, Pt(II) coproporphyrin and Tb(III) labels in an immunometric immunoassay by time-resolved electrochemiluminescence.     

Determination of Urinary Bis(2-ethylhexyl)phthalate Levels in Non-uremic Subjects by Gas Chromatography

Abstract

In vivo studies of urinary bis(2-ethylhexyl)phthalate (DEHP) levels in dogs and in non-uremic patients undergoing hemodialysis treatments for psoriasis were undertaken. Dogs were divided into 3 groups: Control, Sham-Operated, and Nephrectomized. Each dog received 225 mg DEHP per kilogram body weight via the femoral vein. Each of the non-uremic patients underwent hemodialysis therapy for 4–5 hours once a week for four consecutive weeks to treat their psoriatic condition. Specimens of 2 4 hr urine were collected and analyzed for DEHP by gas chromatography. The detection limit of DEHP in urine is 15 ng/ml. No detectable DEHP was found in the urine of all pre-injection specimens obtained from all three groups of dogs. The total urinary DEHP concentrations for the four day period were found to be 76.1 and 192.2 μg for the Control and the Sham-Operated dogs, respectively. No urine samples could be collected from the Nephrectomized dogs. DEHP levels were found in the 24 hr urine specimens from some of the non-uremic patients undergoing hemodialysis therapy. The DEHP concentrations ranged from non-detectable to 159.8 yg/24 hrs. Normal renal function seems to be necessary for the excretion of non-metabolized DEHP.     

Preparation,characterization, and binding profile of imprinted semi-IPN cryogel composite for aluminum

Human body is greatly exposed to aluminum due to its high abundance in the environment. This nonessential metal is a threat to the patients of chronic renal disorders, as it is easily retained in their plasma and quickly accumulates in different tissues. Thus, there is great need to remove it from the aqueous environment. In this study, Al³⁺ imprinted semiinterpenetrating polymer network (semi-IPN)-based cryogel composite was prepared and applied for the purification of environmental and drinking water samples from aluminum. Poly (2-hydroxyethyl methacrylate) (pHEMA) discs were produced via cryogenic treatment and imprinted semi-IPN was introduced to the 3-(trimethoxysilyl) propyl acrylatemodified macroporous cryogel discs. The adsorption properties and selectivity of the aluminum (III) imprinted semi-IPN cryogel composite were studied in detail. The imprinted semi-IPN cryogel composite showed good selectivity towards aluminum (III) ions with the imprinting factor (IF) of 76.4 in the presence of competing copper (II), nickle (II), and iron (III) ions. The maximum adsorption capacity of 271 μmol g^-1 was obtained for aluminum (III) at pH 7.0 within 10 min using imprinted semi-IPN cryogel composite. The good selectivity and reusability of aluminum (III)-imprinted semi-IPN cryogel composite makes this material an eligible candidate for the purification of drinking water from aluminum (III) leaving important minerals remained in the water.     

Alkenyl selenols and selenocyanates: synthesis, spectroscopic characterization by photoelectron spectroscopy, and quantum chemical study

Vinyl, allyl, and homoallyl selenols were easily prepared by a chemoselective reduction of the corresponding selenocyanates with aluminum hydrides. Two stable vinyl and five stable allyl conformers of both series were predicted on the potential-energy surface. The interaction of SeH or SeCN groups with the vinyl group has been investigated with UV photoelectron spectroscopy and quantum chemical calculations, using the MP2/cc-pVTZ and B3LYP/cc-pVTZ levels. In the vinyl derivatives, a surprisingly strong direct conjugation of the selenium lone electron pair and the C=C double bond was observed. On the other hand, in allyl position the selenium lone pair is independent on the C=C double bond, and the hyperconjugation between the Se-C bond and the double bond is the ruling effect. Thus is clarified the type and extent of the interaction between the SeH or SeCN group and the unsaturated moiety.     

Improved Determination of Aluminum in Serum by Electrothermal Atomic Absorption Spectrometry and Zeeman Background Correction

Abstract

A simple but reliable method for the determination of aluminum in serum by flameless atomic absorption spectrometry is described. By use of the Zeeman background correction, the interferences are eliminated. However, considering the numerous possible sources of contamination, extreme precautions are necessary both when taking and storing the serum. The procedures preceding the dosage per se must be minimized. The within-day and clay-to-day precision data (CV %) was 3.28 and 3.82 respectively. The average recovery for aluminum was 97.5 %. We used this method on serum from 30 healthy subjects and from 300 patients on hemodialysis. The mean aluminum concentration for the healthy subjects was 5.35 μg/l (SD ± 0.53) while the values for the hemodialyzed patients ranged from 20 to 220 μg/l.     

Development of an irradiation/shielding cavity for in vivo neutron activation analysis of manganese in human bone

Summary Manganese is essential to human life for normal neurological and skeletal functions. Longstanding, excessive exposure to Mn compounds may result in manganism, a Parkinson's disease like syndrome. Prolonged exposure to Mn at low levels can result in memory deficit, loss of motor control and reduction in the refinement of certain bodily motions. A feasibility study of measuring Mn concentrations in human bone with in vivo neutron activation analysis (IVNAA) was previously reported.¹ Since then, an irradiation/shielding cavity, consisting of moderator, gamma-ray filter, neutron reflector, and shield walls, was constructed for the clinical application of Mn IVNAA,² and an upgraded IVNAA system is reported here. The minimum detectable limit is 0.081 mg in the hand, which is toward the lower end of the estimated bone Mn level of 0.065 to 1 mg in the hand of healthy subjects. A significantly lower radiation dose is delivered than in the reported feasibility study.     

Determination of Aluminium by Electrothermal Atomization Atomic Absorption Spectrometry in Serum to Characterize Hemodialysis Toxicity

A simple and cost-effective method is described for the determination of aluminum by electrothermal atomic absorption spectrometry (ET-AAS) in serum of hemodialysis patients and healthy subjects. The only preparative step required is the dissolution of the serum sample in 0.2% magnesium nitrate matrix modifier and separate diluents 0.01 M EDTA and 0.1% Triton X-100. The calibration curve was linear from 20 to 100 µg/L with correlation coefficients of 0.9993 and 0.9998 for EDTA and Triton X-100, respectively. The sensitivity of the method for aluminum at the 309.3 nm line was 74 pg. The instrumental and method limits of detection were 2.2 µg/L and 4.4 µg/L, respectively. The aluminum concentrations of forty serum samples from hemodialysis patients and healthy subjects were determined and the mean values were 170.9 ± 6.8 µg/L and 47.3 ± 9.3 µg/L, respectively, whereas the permissible limit for aluminum in blood serum is 10 µg/L. The high level of Al in serum was related to oral phosphate binding agents and dialysis treatment.     

Direct determination of trace aluminum with quercetin by reversed-phase high performance liquid chromatography

The determination of trace levels of aluminum by high performance liquid chromatography (HPLC) with spectrophotometric detection using quercetin, a bioactive substance as a pre-column reagent, is developed in this paper. The Al-quercetin chelate was separated on a reversed-phase ODS column with a mobile phase consisting of 70% water (pH 1.0 with perchloric acid) and 30% methanol, and detected at its maximum of 415 nm. The response was linear over the 1.0×10⁻⁷ to 8.0×10⁻⁵ M concentration range with a detection limit of 5.0×10⁻⁸ M and a relative standard deviation of 1.0% at the 5×10⁻⁶ M level. The analysis was free from common ions except iron, which could be successfully screened by 1,10-phenanthroline. This method has been employed to the determination of Al in environmental and biological samples. Moreover, direct speciation of labile monomeric Al, the toxic form of Al, in natural water by the present technique was explored. The coordination ratio of Al complex with quercetin was also elucidated by HPLC combined with molar ratio method. Only a 1:1 complex was formed. Because quercetin exists in body, a preliminary thinking of in vivo determination of Al is provided in this study.     

HPLC-AAS hybrid technique for studying the speciation of trace metals (Al,Fe, Si,Hg) in biological fluids: A review of applications,recent experiences and perspectives

A method developed using the combination of HPLC and AAS enabling both qualitative and quantitative study of the protein binding and speciation of trace metals in biological fluids at clinical relevant levels is reviewed. The whole system was made metal-free by using polymer-based columns, column holders and tubing and by the insertion of a silica-based scavenger column placed immediately before the injection valve to selectively retain any trace of aluminum and iron originating from buffer solutions and recipients. ETAAS instrumental conditions were carefully selected to eliminate interferences secondary to the salt gradient elution. Particular attention was paid to the choice of HPLC columns. Protein recoveries varied between 95 and 105% and trace metal recoveries were close to 100%. Intra-assay and inter-assay CVs of the HPLC/AAS hybrid technique were below 10%. Because of its high sensitivity, the method can be used at clinically relevant concentrations and was applied successfully to study (i) the interaction between iron and aluminum for binding to transferrin, (ii) the influence of citrate on the transferrin binding of aluminum, (iii) the speciation of silicon in the serum of dialysis patients and (iv) the toxicity of mercury compounds in cell cultures.     

Bioactive constituents from chinese natural medicines. XXIV. Hypoglycemic effects of Sinocrassula indica in sugar-loaded rats and genetically diabetic KK-A(y) mice and structures of new acylated flavonol glycosides, sinocrassosides A(1), A(2), B(1), and B(2)

The methanolic extract from the whole plant of Sinocrassula indica (Crassulaceae) was found to inhibit the increase in serum glucose levels in oral administration of sucrose and glucose in rats at a dose of 250 mg/kg (p.o.). However, the extract did not inhibit the increase in serum glucose levels after intraperitoneal administration of glucose in these animals but did partly inhibit the gastric emptying. On the other hand, this extract significantly inhibited the increase in serum glucose levels after administration for 2 weeks in KK-A(y) mice, a genetically type II diabetic mice, at a dose of 250 mg/kg/d (p.o.) without significant changes of the weights of body, liver, and visceral fat. From the extract, four new acylated flavonol glycosides, sinocrassosides A(1), A(2), B(1), and B(2), were isolated together with 11 flavonoids and 2 megastigmanes. The absolute stereostructures of the four new compounds were elucidated on the basis of chemical and physicochemical evidence.